Does trastuzumab increase the risk of isolated CNS metastases in patients with breast cancer?

被引：0

作者：

Abrey, LE ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA

来源：

NATURE CLINICAL PRACTICE NEUROLOGY | 2006年 / 2卷 / 06期

关键词：

brain metastasis; breast cancer; CNS; HER2; trastuzumab;

D O I：

10.1038/ncpneuro0177

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：302 / 303

页数：2

共 6 条

[1] Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma [J].

Bendell, JC ;

Domchek, SM ;

Burstein, HJ ;

Harris, L ;

Younger, J ;

Kuter, I ;

Bunnell, C ;

Rue, M ;

Gelman, R ;

Winer, E .

CANCER, 2003, 97 (12) :2972-2977

[2] Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy [J].

Burstein, HJ ;

Lieberman, G ;

Slamon, DJ ;

Winer, EP ;

Klein, P .

ANNALS OF ONCOLOGY, 2005, 16 (11) :1772-1777

[3] Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer [J].

Clayton, AJ ;

Danson, S ;

Jolly, S ;

Ryder, WDJ ;

Burt, PA ;

Stewart, AL ;

Wilkinson, PM ;

Welch, RS ;

Magee, B ;

Wilson, G ;

Howell, A ;

Wardley, AM .

BRITISH JOURNAL OF CANCER, 2004, 91 (04) :639-643

[4] The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma [J].

Lai, R ;

Dang, CT ;

Malkin, MG ;

Abrey, LE .

CANCER, 2004, 101 (04) :810-816

[5]

Lower Elyse E, 2003, Clin Breast Cancer, V4, P114, DOI 10.3816/CBC.2003.n.016

[6] Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival [J].

Miller, KD ;

Weathers, T ;

Haney, LG ;

Timmerman, R ;

Dickler, M ;

Shen, J ;

Sledge, GW .

ANNALS OF ONCOLOGY, 2003, 14 (07) :1072-1077

← 1 →